We are live on
!
Find out more
CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$203M
1-Year Est. Return
17.67%
This Fund
S&P 500
This Quarter
Est. Return
-2.78%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$550M
AUM Growth
-$25.8M
(-4.5%)
Cap. Flow
-$3.46M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
8.93%
Holding
683
New
116
Increased
168
Reduced
251
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.19M |
| 2 |
Intel
INTC
|
+$2.13M |
| 3 |
HCA Healthcare
HCA
|
+$2.1M |
| 4 |
AT&T
T
|
+$2.05M |
| 5 |
Target
TGT
|
+$2.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wabtec
WAB
|
+$2.95M |
| 2 |
Marathon Petroleum
MPC
|
+$2.83M |
| 3 |
Occidental Petroleum
OXY
|
+$2.71M |
| 4 |
Dow Inc
DOW
|
+$2.68M |
| 5 |
Citizens Financial Group
CFG
|
+$2.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.39% |
| 2 | Financials | 16.43% |
| 3 | Healthcare | 14.65% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Foghorn Therapeutics
FHTX
$371M
| $129K | 0.02% |
25,819
-344
| -1% | -$2.65K |
|
527
Sutro Biopharma
STRO
$423M
| $124K | 0.02% |
3,569
-47
| -1% | -$2.05K |
|
528
Valley National Bancorp
VLY
$8.1B
| $120K | 0.02% |
14,004
-99,291
| -88% | -$901K |
|
529
First Horizon
FHN
$12B
| $117K | 0.02% |
10,662
-4,311
| -29% | -$53.4K |
|
530
Vir Biotechnology
VIR
$1.5B
| $117K | 0.02% |
12,462
+2,084
| +20% | +$29.7K |
|
531
Erasca
ERAS
$6.29B
| $114K | 0.02% |
58,045
+2,979
| +5% | +$7.63K |
|
532
Annexon
ANNX
$883M
| $110K | 0.02% |
46,698
-563
| -1% | -$1.7K |
|
533
Baytex Energy
BTE
$3.06B
| $110K | 0.02% |
24,887
| – | – |
|
534
CytomX Therapeutics
CTMX
$750M
| $105K | 0.02% |
81,352
-1,063
| -1% | -$1.67K |
|
535
BioAtla
BCAB
$5.76M
| $104K | 0.02% |
1,224
-7
| -0.6% | -$892 |
|
536
Century Therapeutics
IPSC
$357M
| $103K | 0.02% |
51,520
-655
| -1% | -$1.74K |
|
537
C4 Therapeutics
CCCC
$400M
| $88.3K | 0.02% |
47,456
-591
| -1% | -$1.8K |
|
538
Tenaya Therapeutics
TNYA
$165M
| $87.7K | 0.02% |
34,408
-439
| -1% | -$1.84K |
|
539
Fate Therapeutics
FATE
$322M
| $87.6K | 0.02% |
41,337
-526
| -1% | -$1.74K |
|
|
KZR
540
DELISTED
Kezar Life Sciences
KZR
| $87.6K | 0.02% |
7,358
-99
| -1% | -$1.75K |
|
541
Shattuck Labs
STTK
$682M
| $77.5K | 0.01% |
50,973
+610
| +1% | +$1.39K |
|
|
NGM
542
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $54.8K | 0.01% |
51,176
-545
| -1% | -$1.13K |
|
|
KRON
543
DELISTED
Kronos Bio
KRON
| $53.8K | 0.01% |
41,351
+563
| +1% | +$910 |
|
544
Nkarta
NKTX
$176M
| $53.7K | 0.01% |
38,645
-551
| -1% | -$1.04K |
|
545
Adicet Bio
ACET
$75.9M
| $52.3K | 0.01% |
2,388
-30
| -1% | -$1.06K |
|
546
Agilent Technologies
A
$42B
| – | – |
-11,704
| Closed | -$1.41M |
|
547
Albertsons Companies
ACI
$5.89B
| – | – |
-87,424
| Closed | -$1.91M |
|
|
ADAP
548
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-13,166
| Closed | -$12.2K |
|
549
AES
AES
$10.5B
| – | – |
-40,441
| Closed | -$838K |
|
550
Akamai
AKAM
$16.9B
| – | – |
-2,747
| Closed | -$247K |
|
Similar funds
NWM
EECFX
PSB
HIA
NMG
EECFX
BC
EFA
Cornercap Investment Counsel's Q3 2023 Portfolio in Review
As of Q3 2023, Cornercap Investment Counsel held 683 positions worth $550M, down 4.5% from $575M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Cornercap Investment Counsel's Q3 2023 filing shows 116 new, 168 increased, 251 reduced and 120 closed positions. Its largest new stake was Clorox: 14,394 shares worth $1.89M. The largest sale was Wabtec, an estimated $2.95M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
- Cornercap Investment Counsel's largest Q3 2023 buy was Clorox: 14,394 shares worth $1.89M.
- Cornercap Investment Counsel added most to Kraft Heinz in Q3 2023, an estimated $1.84M increase.
- Cornercap Investment Counsel's biggest Q3 2023 reduction was Automatic Data Processing, cutting an estimated $2.24M.
- Cornercap Investment Counsel fully exited Wabtec in Q3 2023, selling an estimated $2.95M.
- Cornercap Investment Counsel's ten largest holdings make up 8.9% of its $550M portfolio in Q3 2023.
- Cornercap Investment Counsel opened 116 new positions and closed 120 in Q3 2023.
- Cornercap Investment Counsel's portfolio value fell 4.5% quarter-over-quarter to $550M.
Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.